Liver cancer stem cells: Recent progress in basic and clinical research

• Main Authors: Taro Yamashita, Shuichi Kaneko
• Format: Article
• Language: English
• Published: Elsevier 2021-06-01
• Series: Regenerative Therapy
• Subjects: Alpha-fetoprotein; Cancer stem cells; CD90; EpCAM; Hepatocellular carcinoma; Laminin gamma 2 monomer
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352320421000225

The cancer stem cell (CSC) hypothesis was proposed over 4 decades ago and states that tumor growth is maintained by a small subset of cancer cells analogous to normal tissue stem cells in terms of self-renewal and differentiation capacity. Advances in CSC isolation were initially achieved in hematological malignancies and later in solid tumors, including hepatocellular carcinoma (HCC), the major histological type of liver cancer. Increasing evidence suggests the importance of liver CSCs for tumor growth, metastasis, and chemo/radiation resistance in HCC, but the application of the liver CSC concept for the clinical diagnosis and treatment of HCC has not yet been achieved to the extent initially expected. Furthermore, the heterogeneity and plasticity of liver CSCs has recently been noted and might be related to drug resistance and the rapid growth and/or metastasis of the tumor after treatment. Here, we introduce our recent advancement in liver CSC research and discuss the clinical implications, which may lead to the development of improved diagnostics and treatment in HCC.